rs727504354
Variant summary
Our verdict is Pathogenic. Variant got 11 ACMG points: 11P and 0B. PS1PM1PM2PP2PP3_Moderate
The NM_001018005.2(TPM1):c.762T>A(p.Asp254Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another nucleotide change resulting in same amino acid change has been previously reported as Likely pathogenicin Lovd.
Frequency
Consequence
NM_001018005.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 11 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TPM1 | NM_001018005.2 | c.762T>A | p.Asp254Glu | missense_variant | 8/10 | ENST00000403994.9 | NP_001018005.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TPM1 | ENST00000403994.9 | c.762T>A | p.Asp254Glu | missense_variant | 8/10 | 1 | NM_001018005.2 | ENSP00000385107 | A1 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, no assertion criteria provided | clinical testing | Stanford Center for Inherited Cardiovascular Disease, Stanford University | Jul 24, 2013 | Note this variant was found in clinical genetic testing performed by one or more labs who may also submit to ClinVar. Thus any internal case data may overlap with the internal case data of other labs. The interpretation reviewed below is that of the Stanford Center for Inherited Cardiovascular Disease. The genetic test results were re-reviewed January 7th, 2014 and again on July 7th, 2015. There is new case and control data. p.Asp254Glu (c.762 T>A) in the TPM1 gene. We have seen this in a father and son who both have restrictive cardiomyopathy. Based on the moderate case data and absence in controls, we consider it a variant of uncertain significance, probably disease causing. The variant has been seen in at least 2 unrelated cases of HCM (not including this patent's case). The testing lab shared that they have seen it in one other family. Specifically, an individual diagnosed with HCM <20yo, with a family history of HCM and sudden death. Another testing lab shared that they have seen the variant in a 40yo Black female with HCM and a family history of sudden death. In silico analysis with PolyPhen 2 predicts the variant to be probably damaging. No other variants have been reported in association with disease at codon 254 or nearby codons. This is a non-conservative amino acid change at a highly conserved position. In total this variant has not been seen in ~70,471 laboratory controls and publicly available general population samples. There is no variation at codon 254 listed in the NHLBI Exome Sequencing Project dataset, which currently includes variant calls on ~6200 Caucasian and African American individuals (as of January 7th, 2014). GeneDx did not observe the variant in 271 normal control individuals of different ethnic backgrounds. There is no variation at codon 254 listed in the Exome Aggregation Consortium dataset (http://exac.broadinstitute.org/), which currently includes variant calls on ~64,000 individuals of European, African, Latino and Asian descent (as of July 7th, 2015). - |
Hypertrophic cardiomyopathy Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Nov 27, 2019 | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0"). This variant has not been reported in the literature in individuals with TPM1-related conditions. ClinVar contains an entry for this variant (Variation ID: 235068). This variant is not present in population databases (ExAC no frequency). This sequence change replaces aspartic acid with glutamic acid at codon 254 of the TPM1 protein (p.Asp254Glu). The aspartic acid residue is highly conserved and there is a small physicochemical difference between aspartic acid and glutamic acid. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at